VCNX · Vaccinex, Inc. · Exempt Offerings
$1.06
At close · Dec 18
Return incl. dividend (before tax)
Going-concern doubt
— flagged Apr 15, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern. Because management’s plans have not yet been finalized and are not within the Company’s control, the implementation of such plans cannot be considered probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.”View the 10-K filed Apr 15, 2025
Market Cap
$2.94M
Shares
2.68M
Volume · Dec 18
94.9K
Avg daily vol (3M)
119.98K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-09-27 | New | Pharmaceuticals | $9,224,732 | $200,155 | 06b |
| 2024-04-12 | New | Pharmaceuticals | $3,499,995 | $1,750,000 | 06b |
| 2024-04-12 | New | Pharmaceuticals | $1,474,520 | $0 | 06b |
| 2024-04-12 | New | Pharmaceuticals | $2,462,090 | $1,240,737 | 06b |
| 2020-09-16 | New | Pharmaceuticals | $2,000,000 | $2,000,000 | 06b |
| 2020-08-11 | New | Pharmaceuticals | $8,000,000 | $8,000,000 | 06b |
| 2020-07-15 | New | Pharmaceuticals | $4,000,000 | $4,000,000 | 06b |
| 2020-02-03 | New | Pharmaceuticals | $7,474,986 | $7,474,986 | 06b |
Showing 1–8 of 8 filings